The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Q1 2026 Management View "We are pleased with our first quarter performance as we delivered strong operating and financial results," said CEO Kurt Ekert, highlighting that "Revenue grew 8% and ...

Six-Month Clinical Data Demonstrate Restoration of Cone-Mediated Vision in Pediatric LCA5 Patients, with Sensitivity Improvements Reaching Normal ...

Unity Software Inc. ( U) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT Ladies and gentlemen, thank you for joining us, and welcome to the Unity Technologies Q1 Earnings Call. [Operator Instructions] ...

Peptide ligands can remove process- and product-related impurities from gene therapies better than protein ligands.

CLI-Anything generates SKILL.md files that AI agents trust and execute. Snyk found 13.4% of agent skills contain critical ...

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

PITTSBURGH, May 04, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2026 and provided a business ...

Specifically, there continues to be evidence that “Big Pharma” still plays an outsized role in influencing what constitutes an “illness” and, therefore, which treatments should be prescribed. Despite ...

Ensuring we secure AI agents with the same rigor and accountability as we do humans is critical to effectively embrace this ...